TESI RAYMOND JOSEPH (President & CEO) purchased 1.0% of their position (15.38K shares) of INMUNE BIO, INC. on the open market
Open‑market purchase worth $98.0K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/16/2024ACC: 0001213900-24-079121
DirectorOfficer10% Owner· President & CEO
+30.76K
Net shares
Net buyer
$98.0K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
30.76K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+15.38K
Price / share
$6.38
Trade value
$98.05K
% of position
1.0%
9/12/2024
1.54M→1.55M
Total
Net shares
+15.38K
Net value
$98.05K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/12/2024 | P · Purchase | +15.38K | $6.38 | $98.05K | 1.0% | 1.54M | 1.55M |
| Total | +15.38K | $98.05K | ||||||
Derivative Transactions1
Common Stock Warrants (right to buy)
Direct
Converts to
Common Stock
15.38K shares
Shares
+15.38K
Strike price
6.40
Held after
15.38K
Exercisable
—
9/12/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Common Stock Warrants (right to buy) Direct | Common Stock15.38K shares | 9/12/2024 | P · Purchase | +15.38K | 6.40 | — | 15.38K |